Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00786539 · ClinicalTrials.gov registry record
Mitochondria Inborn Errors of Metabolism and ANT Defects in Mitochondria Diseases
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 18
- Enrollment target
NCT00786539: Completed study, sponsored by University of California, Irvine.
NCT00786539 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00786539 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
The objective of this research protocol is to continue investigation of the nature and prevalence of mitochondria disease and to aid patients and health care providers in the understanding of these complex disorders. This research study brings together many clinical sub-specialists to address the etiology of these disorders and to develop more effective approaches for their diagnoses and more reliable prognoses.
Interventions
- DEVICE Diffuse Optical Spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2006-10 |
| Est. Completion | 2015-05 |
What the finished NCT00786539 record still lists
NCT00786539 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Diffuse Optical Spectroscopy is the first listed.
NCT00786539 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00786539 about?
NCT00786539 is a clinical study titled "Mitochondria Inborn Errors of Metabolism and ANT Defects in Mitochondria Diseases". The objective of this research protocol is to continue investigation of the nature and prevalence of mitochondria disease and to aid patients and health care providers in the understanding of these complex disorders. This research study brings together many clinical sub-specialists to address the e...
What is the current status of trial NCT00786539?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2006-10. Estimated completion is 2015-05.
What interventions are being tested in trial NCT00786539?
The interventions under investigation include: Diffuse Optical Spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT00786539?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia